相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
Alexander C. Leeksma et al.
HAEMATOLOGICA (2021)
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene
Flora Doffe et al.
CELL DEATH AND DIFFERENTIATION (2021)
TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia
Riccardo Bomben et al.
CLINICAL CANCER RESEARCH (2021)
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia TP53 Disruption, Richter, and Beyond
Wei Ding
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
Stuart J. Blakemore et al.
LEUKEMIA (2020)
Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study
John C. Byrd et al.
CLINICAL CANCER RESEARCH (2020)
Treatment of Chronic Lymphocytic Leukemia
Jan A. Burger
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries
Vincent Carbonnier et al.
SCIENTIFIC REPORTS (2020)
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
Panagiotis Baliakas et al.
HAEMATOLOGICA (2019)
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
Andrew W. Roberts et al.
BLOOD (2019)
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
K. Fischer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Lawrence A. Donehower et al.
CELL REPORTS (2019)
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Panagiotis Baliakas et al.
BLOOD (2019)
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia
Jan A. Burger et al.
BLOOD (2019)
Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment
Christian Brieghel et al.
HAEMATOLOGICA (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL
J. R. Brown et al.
LEUKEMIA (2018)
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Li Ding et al.
CELL (2018)
Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing
Tuomas Tikkanen et al.
HUMAN MUTATION (2018)
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial
Stephan Stilgenbauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
J. Malcikova et al.
LEUKEMIA (2018)
A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation
Eran Kotler et al.
MOLECULAR CELL (2018)
Quantitative Missense Variant Effect Prediction Using Large-Scale Mutagenesis Data
Vanessa E. Gray et al.
CELL SYSTEMS (2018)
Mutational processes shape the landscape of TP53 mutations in human cancer
Andrew O. Giacomelli et al.
NATURE GENETICS (2018)
Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation
Lijian Yu et al.
CLINICAL CANCER RESEARCH (2017)
The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
A. Stengel et al.
LEUKEMIA (2017)
Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification
Lesley-Ann Sutton et al.
HAEMATOLOGICA (2017)
Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia
Gregory Lazarian et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M. Li et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification
Lesley-Ann Sutton et al.
HAEMATOLOGICA (2017)
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
Bernard Leroy et al.
CANCER RESEARCH (2017)
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
Viktor Ljungstrom et al.
BLOOD (2016)
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
Nilah M. Ioannidis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Ferran Nadeu et al.
BLOOD (2016)
Actionable Genes, Core Databases, and Locus-Specific Databases
Amelie Pinard et al.
HUMAN MUTATION (2016)
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al.
HUMAN MUTATION (2016)
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stephan Stilgenbauer et al.
LANCET ONCOLOGY (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The molecular pathogenesis of chronic lymphocytic leukaemia
Giulia Fabbri et al.
NATURE REVIEWS CANCER (2016)
An integrative approach to predicting the functional effects of non-coding and coding sequence variation
Hashem A. Shihab et al.
BIOINFORMATICS (2015)
GESPA: classifying nsSNPs to predict disease association
Jay K. Khurana et al.
BMC BIOINFORMATICS (2015)
TP53: an oncogene in disguise
T. Soussi et al.
CELL DEATH AND DIFFERENTIATION (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
J. Malcikova et al.
LEUKEMIA (2015)
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2014)
Locus-Specific Databases in Cancer: What Future in a Post-Genomic Era? The TP53 LSDB paradigm
Thierry Soussi
HUMAN MUTATION (2014)
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
Bernard Leroy et al.
HUMAN MUTATION (2014)
A general framework for estimating the relative pathogenicity of human genetic variants
Martin Kircher et al.
NATURE GENETICS (2014)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
S. Pospisilova et al.
LEUKEMIA (2012)
Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, Condel
Abel Gonzalez-Perez et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Translating p53 into the clinic
Chit Fang Cheok et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Mutation (variation) databases and registries: a rationale for coordination of efforts
Arleen D. Auerbach et al.
NATURE REVIEWS GENETICS (2011)
Predicting the functional impact of protein mutations: application to cancer genomics
Boris Reva et al.
NUCLEIC ACIDS RESEARCH (2011)
International Cancer Genome Consortium Data Portal-a one-stop shop for cancer genomics data
Junjun Zhang et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2011)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
MutationTaster evaluates disease-causing potential of sequence alterations
Jana Marie Schwarz et al.
NATURE METHODS (2010)
Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP plus
Eugene V. Davydov et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Prateek Kumar et al.
NATURE PROTOCOLS (2009)
Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection
T Soussi et al.
CLINICAL CANCER RESEARCH (2006)
The codon 47 polymorphism in p53 is functionally significant
XX Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations
T Soussi et al.
HUMAN MUTATION (2005)
The challenge of documenting mutation across the genome: The human genome variation society approach
O Horaitis et al.
HUMAN MUTATION (2004)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Predicting deleterious amino acid substitutions
PC Ng et al.
GENOME RESEARCH (2001)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
